Results 91 to 100 of about 461,561 (166)

Gut microbiome-driven modulation of the tumor immune microenvironment optimizes dual checkpoint blockade in advanced non-small-cell lung cancer. [PDF]

ESMO Open
Katayama Y, Fukuda A, Inoue R, Kawachi H, Sawada R, Harada T, Yoshimura A, Okada A, Shiotsu S, Chihara Y, Takemura Y, Yamada T, Nishioka N, Iwasaku M, Tokuda S, Takagi T, Kumagai S, Koyama S, Takayama K, Yamada T.   +19 more
europepmc   +1 more source

Assessing academic capacity and quality assurance in pharmacy education: a focus on the Eastern Mediterranean region. [PDF]

J Pharm Policy Pract
Abedini Z, Awaisu A, Bates I, Mukhalalati B.   +3 more
europepmc   +1 more source

Landscape of diabetic kidney disease drug clinical trials in China (2013-2023): global implications for innovation and policy. [PDF]

Ren Fail
Yang Y, Tan H, Xiao Z, Zhu J, Chen Y, Li G.   +5 more
europepmc   +1 more source

Smart adsorbent frameworks enabling high-efficiency pharmaceutical degradation <i>via</i> adsorption. [PDF]

RSC Adv
Islam M, Khan ZUH, Islam A, Khasim S, Ahmad F, Ahmad N, Alsayer IA.   +6 more
europepmc   +1 more source

Regulatory implementation of Optical Coherence Tomography as an analytical technique in pharmaceutical fillings. [PDF]

Front Med (Lausanne)
Afonso Urich JA, Lara Garcia RA, Wolfgang M, Khinast J.   +3 more
europepmc   +1 more source

Heterogeneous photocatalytic aldehyde alkylative amination for multicomponent synthesis of α-branched amines. [PDF]

Natl Sci Rev
Ou W, Xu Q, Wang Q, Tao Y, Wang J, Teng Z, Li F, Ding J, Liu W, Hou H, Yamakata A, Ohno T, Liu B, Su C.   +13 more
europepmc   +1 more source

Total flavonoids of <i>Abelmoschus manihot</i> (L.) medic attenuate early renal injury in diabetic kidney disease by modulating the LINC00665/miR-379-5p axis. [PDF]

Pharm Biol
Li N, Zeng Y, Fang Y, Wu J, Gu HF, Wang Y.   +5 more
europepmc   +1 more source

Correction: Secondary metabolites from <i>Lobaria pulmonaria</i> (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis. [PDF]

RSC Adv
Nguyen HT, Badavath VN, Maji S, Polimati H, Okello E, Bunce RA, Thuan NH, Nuzul Hakimi Wan Salleh WM, Tatipamula VB.   +8 more
europepmc   +1 more source

Perspectives on the Influence of Pharmaceutical and MedTech Companies on Deprescribing Decisions and Conference Sponsorship: A Survey Study. [PDF]

Basic Clin Pharmacol Toxicol
Jungo KT, Boyd CM, Farrell B, McCarthy C.   +3 more
europepmc   +1 more source

A pragmatic phase II trial evaluating treatment strategies using immune checkpoint inhibitors for metastatic esophageal cancer patients with severe dysphagia. [PDF]

ESMO Gastrointest Oncol
Nagata Y, Arai H, Izawa N, Inagaki C, Sugaya A, Hirata K, Tsushima T, Moriwaki T, Masuishi T, Nagatani Y, Harada K, Taguri M, Sunakawa Y.   +12 more
europepmc   +1 more source